C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor

Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210)
12/2001
12/20/2001	CA2413022A1 Whole cell engineering by mutagenizing a substantial portion of a starting genome, combining mutations, and optionally repeating
12/20/2001	CA2413020A1 Detection of nucleic acids by type-specific hybrid capture method
12/20/2001	CA2413013A1 Novel motor proteins and methods for their use
12/20/2001	CA2413003A1 Immunoassays for anti-hcv antibodies
12/20/2001	CA2412998A1 Methods of dissociating nongenotropic from genotropic activity of steroid receptors
12/20/2001	CA2412902A1 Genes for s-adenosyl l-methionine: jasmonic acid carboxyl methyltransferase and a method for the development of pathogen- and stress-resistant plants using the genes
12/20/2001	CA2412821A1 Plant-signalling ligand like proteins
12/20/2001	CA2412769A1 Toxicity typing using mesenchymal stem cells
12/20/2001	CA2412665A1 Scramblase 2
12/20/2001	CA2412664A1 Regulatable, catalytically active nucleic acids
12/20/2001	CA2412663A1 A human homologue of the dbf4/ask1 protein, nucleic acids, and methods related to the same
12/20/2001	CA2412579A1 Methods to identify polynucleotide and polypeptide sequences which may be associated with physiological and medical conditions
12/20/2001	CA2412521A1 Thyrotropin-releasing hormone receptor-like gpcr (gprfwki)
12/20/2001	CA2412457A1 Modulation of abscisic acid signal transduction in plants
12/20/2001	CA2412447A1 Method of increasing recovery of heterologous active enzymes produced in plants
12/20/2001	CA2412343A1 Immunization through oral administration of a vaccine with an edible product
12/20/2001	CA2412257A1 Pro-apoptotic fragments of the dengue virus envelope glycoproteins
12/20/2001	CA2412223A1 Compositions and methods for the therapy and diagnosis of colon cancer
12/20/2001	CA2412217A1 Hiv-1 reporter viruses and their use in assaying anti-viral compounds
12/20/2001	CA2411908A1 Detection of mycosphaerella using the polymerase chain reaction
12/20/2001	CA2411740A1 Improved combinatorial libraries by recombination in yeast and analysis method
12/20/2001	CA2411472A1 Cd154 variants
12/20/2001	CA2411462A1 Integrated herd management system utilizing isolated populations of x-chromosome bearing and y-chromosome bearing spermatozoa
12/20/2001	CA2411401A1 Means and methods for monitoring antiretroviral therapy and guiding therapeutic decisions in the treatment of hiv/aids
12/20/2001	CA2411346A1 Biosynthetic oncolytic molecules and uses therefor
12/20/2001	CA2411278A1 Compositions and methods for the therapy and diagnosis of colon cancer
12/20/2001	CA2411231A1 Codon optimised recombinant dermaphagoides allergens
12/20/2001	CA2411036A1 Combinatorial production of nucleotide and nucleoside (xitp)analogues
12/20/2001	CA2410659A1 Transgenic mice containing nuclear hormone receptor gene disruptions
12/20/2001	CA2410610A1 Human kinases
12/20/2001	CA2410532A1 Nucleotide and amino acid sequences of oocyte factors for altering ovarian follicular growth in vivo or in vitro
12/20/2001	CA2410229A1 Vaccine for congenital tremors in pigs
12/20/2001	CA2409400A1 Dielectrically-engineered microparticles
12/20/2001	CA2409315A1 Protein phosphatases
12/20/2001	CA2376268A1 Method of inducing gene expression in plant and plant treated thereby
12/20/2001	CA2351275A1 Use of polypeptides or nucleic acids for the diagnosis or treatment of skin disorders and wound healing and for the identification of pharmacologically active substances
12/19/2001	EP1164202A1 Mismatch-recognizing molecules
12/19/2001	EP1164196A1 Retroviral vectors
12/19/2001	EP1164195A2 Adeno-associated virus with inverted terminal repeat sequences as promoter
12/19/2001	EP1164194A2 Protein production in transgenic plant seeds
12/19/2001	EP1164193A1 Plant-signalling ligand like proteins
12/19/2001	EP1164192A1 Sorbitol dehydrogenase, gene encoding the same and use thereof
12/19/2001	EP1164191A1 Novel guanosine triphosphate (gtp)-binding protein-coupled receptor proteins, bg3
12/19/2001	EP1164190A1 Rheumatoid arthritis gene and method for diagnosing rheumatoid arthritis
12/19/2001	EP1164189A1 Method for cloning and producing the RsaI restriction endonuclease in E.coli
12/19/2001	EP1164188A1 Auxotrophic Mycobacterium mutants and tuberculosis vaccine
12/19/2001	EP1164142A1 Novel proteins and uses thereof
12/19/2001	EP1163912A1 Gene therapeutics
12/19/2001	EP1163844A1 Transgenic mollusc and method for constructing the same
12/19/2001	EP1163524A2 Methods of screening for colorectal cancer modulators
12/19/2001	EP1163522A1 Method for detecting superantigen activity in a biological sample
12/19/2001	EP1163520A1 Porous coatings bearing ligand arrays
12/19/2001	EP1163519A1 Protein isolation and analysis
12/19/2001	EP1163515A1 Therapeutic and diagnostic tools for impaired glucose tolerance conditions
12/19/2001	EP1163514A1 AN $i(IN VIVO) AND $i(IN VITRO) MODEL FOR CUTANEOUS PHOTOAGING AND OXIDATIVE DAMAGE
12/19/2001	EP1163374A2 Arrays of organic compounds attached to surfaces
12/19/2001	EP1163373A1 Antisense modulation of cellular inhibitor of apoptosis-1 expression
12/19/2001	EP1163371A2 Methods for purifying dna using immobilized capture probes
12/19/2001	EP1163370A2 Transposon-based genetic marker
12/19/2001	EP1163367A2 Analysis of differential gene expression
12/19/2001	EP1163366A1 Rational selection of peptides presumed to have a specific function derived from identified nucleotide or peptide sequences
12/19/2001	EP1163364A1 Screening method involving mgdg synthase
12/19/2001	EP1163359A1 Method for generating transcriptionally active dna fragments
12/19/2001	EP1163357A1 Primers-attached vector elongation (pave): a 5'-directed cdna cloning strategy
12/19/2001	EP1163356A1 Retroviral vectors comprising functional and non-functional splice donor and splice acceptor sites
12/19/2001	EP1163355A1 Anti-neoplastic viral agents comprising toxin gene under control of tumour cell-derived transcription factors
12/19/2001	EP1163354A1 Compositions and methods for helper-free production of recombinant adeno-associated viruses
12/19/2001	EP1163353A2 Maize ku80 homolog and uses thereof
12/19/2001	EP1163352A1 Transgenic plants that are resistant to a broad spectrum of pathogens
12/19/2001	EP1163351A1 Chimeric promoters based on the plastocyanin pete promoter from pea
12/19/2001	EP1163350A1 Polynucleotides for mutagenesis in fungus comprising a functional gene in magnaporthe and an impala tranposon
12/19/2001	EP1163349A2 Medical preparations for the treatment of alpha-galactosidase a deficiency
12/19/2001	EP1163348A1 Inducible comtii promoter, chimera gene containing same and transformed plants
12/19/2001	EP1163347A2 Zwittermicin a biosynthetic gene from bacillus cereus
12/19/2001	EP1163346A1 Hybrid synthetase, hybrid peptide and composition containing same
12/19/2001	EP1163345A1 Fungal beta-tubulin genes
12/19/2001	EP1163344A1 Hyphal growth in fungi
12/19/2001	EP1163343A2 Neisseria meningitidis antigenic polypeptides, corresponding polynucleotides and protective antibodies
12/19/2001	EP1163342A1 Chlamydia antigens and corresponding dna fragments and uses thereof
12/19/2001	EP1163341A2 Method for enhancing and/or improving plant growth and/or yield or modifying plant architecture
12/19/2001	EP1163340A1 Compositions and methods for the modification of gene expression
12/19/2001	EP1163339A1 A polypeptide structure for use as a scaffold
12/19/2001	EP1163338A2 HUMAN MESENCHYMAL DNAs AND EXPRESSION PRODUCTS
12/19/2001	EP1163337A2 Vascular adhesion molecules and modulation of their function
12/19/2001	EP1163336A2 Vertebrate protein slit, dna sequence encoding it and uses thereof
12/19/2001	EP1163335A1 MATERIALS AND METHODS RELATING TO MODULATION OF p66 EXPRESSION
12/19/2001	EP1163334A1 Polynucleotide and deduced amino acid sequences from stromal cells
12/19/2001	EP1163333A2 Inhibitors of endothelin-1 synthesis
12/19/2001	EP1163332A1 48 human secreted proteins
12/19/2001	EP1163331A1 50 human secreted proteins
12/19/2001	EP1163330A1 Detection, cloning and sequencing of polypeptides which drive the subcellular localization of proteins
12/19/2001	EP1163327A1 Human protein kinase b gamma polypeptides and a method for disrupting protein kinase b gamma in a non-human
12/19/2001	EP1163324A2 Genetically modified plants having modulated brassinosteroid signaling
12/19/2001	EP1163272A1 Antibodies specific for cyp1b1
12/19/2001	EP1163271A1 Recombinant il-18 antagonists useful in treatment of il-18 mediated disorders
12/19/2001	EP1163269A1 ISOFORMS OF MOUSE SEROTONIN 5-HT2c RECEPTOR
12/19/2001	EP1163267A1 47 human secreted proteins
12/19/2001	EP1163266A2 Barley gene for thioredoxin and nadp-thioredoxin reductase
12/19/2001	EP1163260A1 Process for partitioning of proteins
12/19/2001	EP1163255A1 50 human secreted proteins

1 ... 2918 2919 2920 2921 2922 2923 2924 2925 2926 2927 2928 2929 2930 2931 2932 2933 2934 2935 2936 2937 2938 ... 4023